Background
Methods
Patients and specimens
Renal histopathology
Assessment of NLR expression in kidneys with immunohistochemistry
Detection of NLR expression on various cell types
Cell culture and treatments
Quantitative polymerase chain reaction of NLRs
Statistical analysis
Results
General data of AAV patients
Parameters | Value |
---|---|
Number | 34 |
Gender (male/female) | 12/22 |
Age at diagnosis | 61.7 ± 11.9 |
MPO-ANCA/PR3-ANCA | 30/4 |
ESR (mm/1 h) | 65.8 ± 39.2 |
Scr (μmol/L) | 266.9 (196.3–410.0) |
Proteinuria (g/24 h) | 1.42 ± 1.25 |
Clinical manifestation | |
Skin rash | 5 (14.7%) |
Arthralgia | 3 (8.8%) |
Muscle pain | 5 (14.7%) |
Pulmonary | 18 (52.9%) |
ENT | 10 (29.4%) |
Ophthalmic | 10 (29.4%) |
Gastrointestinal | 3 (8.8%) |
Nervous | 5 (14.7%) |
BVAS | 18.6 ± 5.2 |
Glomeruli per biopsy | 30.0 ± 13.8 |
Glomerular lesions (%) | |
Total crescents | 62.2 ± 21.0 |
Fibrinoid necrosis | 1.3 (0–6.6) |
Glomerulosclerosis | 2.7 (0–10.0) |
Tubulointerstitial lesions | |
Tubular atrophy (−/+/++) | 5/25/4 |
Interstitial infiltration (−/+/++/+++ ) | 0/8/21/5 |
Interstitial fibrosis (−/+/++) | 3/25/6 |
Berden classification n (%) | |
Focal | 5 (14.7) |
Crescentic | 24 (70.6) |
Mixed | 5 (14.7) |
Sclerotic | 0 (0) |